Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of eye disorders in pets
3.2.1.2 Increasing veterinary healthcare expenditure
3.2.1.3 Increasing pet ownership globally
3.2.1.4 Advancements in veterinary ophthalmology
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Lack of insurance coverage
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
3.7 Pricing analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product & Services, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Veterinary care products
5.2.1 Diagnosis
5.2.1.1 Tonometer
5.2.1.2 Ophthalmic test kits
5.2.1.3 Electroretinogram (ERG)
5.2.1.4 Fundus camera
5.2.1.5 Ophthalmoscope
5.2.1.6 Pachymeter
5.2.1.7 Other diagnostic products
5.2.2 Treatment
5.2.2.1 Drugs
5.2.2.1.1 Drug type
5.2.2.1.1.1 Antibiotics
5.2.2.1.1.2 NSAIDs
5.2.2.1.1.3 Corticosteroids
5.2.2.1.1.4 Other drugs
5.2.2.1.2 By route of administration
5.2.2.1.2.1 Oral
5.2.2.1.2.2 Topical
5.2.2.1.2.3 Injectable
5.2.2.1.3 By distribution channel
5.2.2.1.3.1 Veterinary hospitals pharmacies
5.2.2.1.3.2 Retail drug stores
5.2.2.1.3.3 Pet specialty stores
5.2.2.1.3.4 E-commerce
5.2.2.2 Lenses
5.2.2.2.1 Bandage lenses
5.2.2.2.2 Intraocular lenses
5.2.2.3 Laser devices
5.3 Veterinary care services
Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Canine
6.3 Feline
6.4 Equine
6.5 Bovine
6.6 Other animal type
Chapter 7 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Eyelid abnormalities
7.3 Cataract
7.4 Glaucoma
7.5 Retinal disorders
7.6 Uveitis
7.7 Conjunctivitis
7.8 Corneal ulcers
7.9 Other indications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals
8.3 Diagnostic laboratories
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 An-Vision GmbH
10.2 Bausch & Lomb Inc.
10.3 Boehringer Ingelheim International GmbH
10.4 Ceva Sante Animale
10.5 Dechra Pharmaceuticals PLC
10.6 IRIDEX Corporation
10.7 I-Med Animal Health
10.8 LKC Technologies, Inc.
10.9 Neuronix Ltd.
10.10 OptoMed
10.11 Reichert, Inc.
10.12 Zoetis Services LLC
